Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerrit Jansen

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Rheumatology and Therapy|September 14, 2020
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in EvidencioHelen R Gosselt, Maxime M A Verhoeven, Maurits C F J de Rotte, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2023
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled TrialKristina Lend, Frieda A Koopman, Jon Lampa, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 27, 2018
Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexateDurga M S H Chandrupatla, Carla F M Molthoff, Wayne I G R Ritsema, et al.
Annals of the Rheumatic Diseases|June 1, 2023
Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)Luis Fernando Perez-Garcia, Esther Röder, Bouwe P Krijthe, et al.
Cellular and Molecular Life Sciences : CMLS|March 17, 2026
Monocytes from inflammatory arthritis patients accumulate methotrexate and their transcriptome predicts methotrexate clinical responseIsrael Ríos, María Teresa Schiaffino, Baltasar López-Navarro, et al.
Molecular Pharmaceutics|December 15, 2018
F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational ApproachStefan T G Bruijnen, Durga M S H Chandrupatla, Leonardo Giovanonni, et al.
Blood|June 21, 2008
Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 proteinRuud Oerlemans, Niels E Franke, Yehuda G Assaraf, et al.
Oncotarget|August 20, 2016
Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitorsNiels E Franke, Gertjan L Kaspers, Yehuda G Assaraf, et al.
Basic & Clinical Pharmacology & Toxicology|July 8, 2024
Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non-target red blood cells of patients with Crohn's diseaseMaartje M van de Meeberg, Janani Sundaresan, Marry Lin, et al.
Ebiomedicine|December 25, 2018
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesotheliomaRocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Rheumatology and Therapy|September 14, 2020
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in EvidencioHelen R Gosselt, Maxime M A Verhoeven, Maurits C F J de Rotte, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2023
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled TrialKristina Lend, Frieda A Koopman, Jon Lampa, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 27, 2018
Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexateDurga M S H Chandrupatla, Carla F M Molthoff, Wayne I G R Ritsema, et al.
Annals of the Rheumatic Diseases|June 1, 2023
Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)Luis Fernando Perez-Garcia, Esther Röder, Bouwe P Krijthe, et al.
Cellular and Molecular Life Sciences : CMLS|March 17, 2026
Monocytes from inflammatory arthritis patients accumulate methotrexate and their transcriptome predicts methotrexate clinical responseIsrael Ríos, María Teresa Schiaffino, Baltasar López-Navarro, et al.
Molecular Pharmaceutics|December 15, 2018
F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational ApproachStefan T G Bruijnen, Durga M S H Chandrupatla, Leonardo Giovanonni, et al.
Blood|June 21, 2008
Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 proteinRuud Oerlemans, Niels E Franke, Yehuda G Assaraf, et al.
Oncotarget|August 20, 2016
Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitorsNiels E Franke, Gertjan L Kaspers, Yehuda G Assaraf, et al.
Basic & Clinical Pharmacology & Toxicology|July 8, 2024
Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non-target red blood cells of patients with Crohn's diseaseMaartje M van de Meeberg, Janani Sundaresan, Marry Lin, et al.
Ebiomedicine|December 25, 2018
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesotheliomaRocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.
Pageof 19